Skip to main content

Post-IPO Equity Companies in Cambridge

Explore 43 post-ipo equity startups based in Cambridge, United States. Access verified founder contact information and fundraising data.

Total Companies
43
Total Funding
$3.9B
Avg Funding
$217.4M
Industries
5

Export 43 Post-IPO Equity Companies in Cambridge

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Biotechnology
$120.0M
raised

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

May 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$280.0M
raised

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$130.0M
raised

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$366.9M
raised

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$100.0M
raised

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Jan 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 43 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biotechnology
$21.0M
raised

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$25.5M
raised

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$75.0M
raised

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$5.0M
raised

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$76.0M
raised

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 43 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biotechnology
$125.0M
raised

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$40.0M
raised

Omega Therapeutics offers a proprietary epigenomic programming platform.

Feb 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$34.2M
raised

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Analytics
$12K
raised

Oxys is an IIoT company that provides services and products for the industrial of the internet of things.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bioinformatics
$1.3B
raised

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 43 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Auto Insurance
$15.0M
raised

EverQuote is an independent insurance marketplace and is a free service that helps consumers compare quotes on auto insurance.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$1.2B
raised

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biopharma
$50.0M
raised

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 26 to 43 of 43 companies

Ready to Connect with Post-IPO Equity Startups in Cambridge?

Get verified founder emails, funding details, and company data for 43 post-ipo equity companies in Cambridge.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked